Cargando…

A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) overlap clinically with parkinsonism or extrapyramidal signs and pathologically with tauopathy. Asymmetric parkinsonism and cortical dysfunctions are classical features of CBD. However, symmetric parkinsonism, frequent falls, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Eun Joo, Cho, Hwa Jin, Jang, Wooyoung, Hur, Dae Young, Kim, Yeong Seok, Lee, Kyung-Hwa, Kim, Sang Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171350/ https://www.ncbi.nlm.nih.gov/pubmed/35668689 http://dx.doi.org/10.3346/jkms.2022.37.e183

Ejemplares similares

Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options
por: Lamb, Ruth, et al.
Publicado: (2016)

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020)

Progressive supranuclear palsy and corticobasal degeneration: novel clinical concepts and advances in biomarkers
por: Parmera, Jacy Bezerra, et al.
Publicado: (2022)

Language impairment in progressive supranuclear palsy and corticobasal syndrome
por: Peterson, Katie A., et al.
Publicado: (2019)

Caregiver strain in progressive supranuclear palsy and corticobasal syndromes
por: Kellermair, Lukas, et al.
Publicado: (2021)

Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020)

Machine learning‐based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2021)

Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Jabbari, Edwin, et al.
Publicado: (2020)

Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy
por: Tse, Nga Yan, et al.
Publicado: (2020)

Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2015)

MAPT ‐Associated Familial Progressive Supranuclear Palsy with Typical Corticobasal Degeneration Neuropathology: A Clinicopathological Report
por: Cullinane, Patrick W., et al.
Publicado: (2023)

Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Swallow, Diane M.A., et al.
Publicado: (2022)

Tau pathology in aged cynomolgus monkeys is progressive supranuclear palsy/corticobasal degeneration- but not Alzheimer disease-like -Ultrastructural mapping of tau by EDX-
por: Uchihara, Toshiki, et al.
Publicado: (2016)

Progression of Microstructural Degeneration in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Longitudinal Diffusion Tensor Imaging Study
por: Zhang, Yu, et al.
Publicado: (2016)

Distinct subcortical tau burden: The tau pallido‐claustral ratio separates progressive supranuclear palsy and corticobasal degeneration
por: Zhao, Chelsey ShengQi, et al.
Publicado: (2021)

Single-nucleus chromatin accessibility profiling highlights distinct astrocyte signatures in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2022)

Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration
por: Koga, Shunsuke, et al.
Publicado: (2023)

Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant
por: Ling, H, et al.
Publicado: (2014)

Abnormal Resting-State Functional Connectivity in Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Bharti, Komal, et al.
Publicado: (2017)

The clinico-metabolic correlates of language impairment in corticobasal syndrome and progressive supranuclear palsy
por: Dodich, Alessandra, et al.
Publicado: (2019)

Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome
por: Whiteside, David J., et al.
Publicado: (2023)

Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Illán-Gala, Ignacio, et al.
Publicado: (2022)

Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome
por: Jatale, Vinayak, et al.
Publicado: (2023)

The prevalence and incidence of progressive supranuclear palsy and corticobasal syndrome: a systematic review and meta-analysis
por: Lyons, Shane, et al.
Publicado: (2023)

Fiber-specific micro- and macroscopic white matter alterations in progressive supranuclear palsy and corticobasal syndrome
por: Uchida, Wataru, et al.
Publicado: (2023)

Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
por: Beyer, Leonie, et al.
Publicado: (2018)

The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)
por: Swallow, Diane M. A., et al.
Publicado: (2023)

The Small Heat Shock Protein HSP25/27 (HspB1) Is Abundant in Cultured Astrocytes and Associated with Astrocytic Pathology in Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Schwarz, Lisa, et al.
Publicado: (2010)

Towards accurate and unbiased imaging-based differentiation of Parkinson’s disease, progressive supranuclear palsy and corticobasal syndrome
por: Correia, Marta M, et al.
Publicado: (2020)

Language Disorder in Progressive Supranuclear Palsy and Corticobasal Syndrome: Neural Correlates and Detection by the MLSE Screening Tool
por: Peterson, Katie A., et al.
Publicado: (2021)

Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome
por: Katzdobler, Sabrina, et al.
Publicado: (2022)

Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy
por: Piras, Antonio, et al.
Publicado: (2016)

Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer’s disease, corticobasal degeneration and progressive supranuclear palsy brains
por: Malarte, Mona-Lisa, et al.
Publicado: (2022)

Presence of Skin α-Synuclein Deposits Discriminates Parkinson’s Disease from Progressive Supranuclear Palsy and Corticobasal Syndrome
por: Giannoccaro, Maria Pia, et al.
Publicado: (2022)

Corticobasal degeneration and corticobasal syndrome: A review
por: Constantinides, Vasilios C., et al.
Publicado: (2019)

Understanding fatigue in progressive supranuclear palsy
por: Ahn, Jong Hyeon, et al.
Publicado: (2021)

Clinical and pathologic features of cognitive-predominant corticobasal degeneration
por: Sakae, Nobutaka, et al.
Publicado: (2020)

Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care
por: Bluett, Brent, et al.
Publicado: (2021)

PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers
por: Vasilevskaya, Anna, et al.
Publicado: (2020)

The Rate of Decrease in Brain Perfusion in Progressive Supranuclear Palsy and Corticobasal Syndrome May Be Impacted by Glycemic Variability—A Pilot Study
por: Alster, Piotr, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5qp4lbi8iel8eo8j816grr4gb0